Gilead scores a $33M set­tle­ment from its cam­paign against ‘colos­sal fi­nan­cial fraud’

More than 18 months and 860 court fil­ings lat­er, Gilead has bagged a new set­tle­ment in its cam­paign against a group of com­pa­nies that par­tic­i­pat­ed in an al­leged fraud aimed at its free meds pro­gram for peo­ple at risk of HIV.

Gilead, along with health­care clin­ic Well Care and ex­ecs Mike Pea­cock and Sha­juan­drine Gar­cia, reached a set­tle­ment worth $33 mil­lion last week. Gilead is drop­ping its al­le­ga­tions against the clin­ic, and the par­ties in­volved will pay their own at­tor­ney fees.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.